World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
74
Citations
22046
World Ranking
2047
National Ranking
79

Kyogo Itoh publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Kyogo Itoh sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 473 publications — 88th percentile

88% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Kyogo Itoh D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Kyogo Itoh sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 74 D-Index — 59th percentile

59% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Kyogo Itoh is affiliated with Kurume University in Japan and focuses their research primarily in the fields of Medicine, Immunology and Microbiology, and Biochemistry, Genetics and Molecular Biology. Their work spans several subfields including Oncology, Immunology, Molecular Biology, Pulmonary and Respiratory Medicine, and Surgery.

The scientist has contributed extensively to topics related to Cancer Immunotherapy and Biomarkers, Immunotherapy and Immune Responses, vaccines and immunoinformatics approaches, Prostate Cancer Treatment and Research, Colorectal and Anal Carcinomas, Colorectal Cancer Treatments and Studies, as well as Peptidase Inhibition and Analysis.

Kyogo Itoh's recent publications include the following papers:

  • Multicenter International Society for Immunotherapy of Cancer Study of the Consensus Immunoscore for the Prediction of Survival and Response to Chemotherapy in Stage III Colon Cancer, 2020, Journal of Clinical Oncology
  • A randomized phase III trial of personalized peptide vaccination for castration-resistant prostate cancer progressing after docetaxel, 2020, Oncology Reports
  • Mixed 20-peptide cancer vaccine in combination with docetaxel and dexamethasone for castration-resistant prostate cancer: a randomized phase II trial, 2020, Cancer Immunology Immunotherapy
  • Early phase II study of mixed 19-peptide vaccine monotherapy for refractory triple-negative breast cancer, 2020, Cancer Science
  • Identification of biomarkers for personalized peptide vaccination in 2,588 cancer patients, 2020, International Journal of Oncology

The scientist frequently publishes in journals such as Molecular and Clinical Oncology, Journal of Clinical Oncology, Oncology Reports, Cancer Immunology Immunotherapy, and Cancer Science.

Collaborations form an important aspect of their research. Kyogo Itoh often works with coauthors including:

  • Shigeki Shichijo
  • Akira Yamada
  • Uhi Toh
  • Masanori Noguchi
  • Shigetaka Suekane

Best Publications

  • International validation of the consensus Immunoscore for the classification of colon cancer: a prognostic and accuracy study

    Franck Pagès;Bernhard Mlecnik;Florence Marliot;Gabriela Bindea;Gabriela Bindea;Gabriela Bindea

  • Towards the introduction of the 'Immunoscore' in the classification of malignant tumours.

    Jérôme Galon;Jérôme Galon;Jérôme Galon;Bernhard Mlecnik;Bernhard Mlecnik;Bernhard Mlecnik;Gabriela Bindea;Gabriela Bindea;Gabriela Bindea;Helen K. Angell;Helen K. Angell;Helen K. Angell

  • Cancer classification using the Immunoscore: a worldwide task force

    Jérôme Galon;Franck Pagès;Francesco M Marincola;Francesco M Marincola;Helen K Angell;Helen K Angell

  • Polymorphism of the 5'-flanking region of the human tumor necrosis factor (TNF)-alpha gene in Japanese.

    T. Higuchi;N. Seki;S. Kamizono;A. Yamada

  • Autologous tumor-specific cytotoxic T lymphocytes in the infiltrate of human metastatic melanomas. Activation by interleukin 2 and autologous tumor cells, and involvement of the T cell receptor.

    Kyogo Itoh;Chris D. Platsoucas;Charles M. Balch

  • A Gene Encoding Antigenic Peptides of Human Squamous Cell Carcinoma Recognized by Cytotoxic T Lymphocytes

    Shigeki Shichijo;Masanobu Nakao;Yasuhisa Imai;Hideo Takasu

  • Identification of MAGE-1 and MAGE-4 proteins in spermatogonia and primary spermatocytes of testis.

    Koichi Takahashi;Shigeki Shichijo;Masanori Noguchi;Masaru Hirohata

  • Immunologic Aspects of the Nonobese Diabetic (NOD) Mouse: Abnormalities of Cellular Immunity

    Shigeki Kataoka;Jo Satoh;Hiroshi Fujiya;Takayoshi Toyota

  • Patterns of human tumor-infiltrating lymphocytes in 120 human cancers.

    Charles M. Balch;Lee B. Riley;Yoon Joo Bae;Marie A. Salmeron

  • Identification of a gene coding for a protein possessing shared tumor epitopes capable of inducing HLA-A24-restricted cytotoxic T lymphocytes in cancer patients.

    Damu Yang;Masanobu Nakao;Shigeki Shichijo;Teruo Sasatomi

  • Cytokine messenger RNA expression in the labial salivary glands of patients with Sjögren's syndrome.

    Yukiko Ohyama;Seiji Nakamura;Goro Matsuzaki;Masanori Shinohara

  • Lichen planus and hepatitis C virus in the northern Kyushu region of Japan

    Y Nagao;M Sata;K Tanikawa;K Itoh

  • Ocular infiltrating CD4+ T cells from patients with Vogt-Koyanagi-Harada disease recognize human melanocyte antigens.

    Sunao Sugita;Hiroshi Takase;Chikako Taguchi;Yasuhisa Imai

  • Multicenter International Society for Immunotherapy of Cancer Study of the Consensus Immunoscore for the Prediction of Survival and Response to Chemotherapy in Stage III Colon Cancer.

    Bernhard Mlecnik;Carlo Bifulco;Gabriela Bindea;Gabriela Bindea;Florence Marliot

  • Identification of a gene coding for a new squamous cell carcinoma antigen recognized by the CTL.

    Masanobu Nakao;Shigeki Shichijo;Toshihiro Imaizumi;Yoshiko Inoue

  • Next‐generation peptide vaccines for advanced cancer

    Akira Yamada;Tetsuro Sasada;Masanori Noguchi;Kyogo Itoh

  • Immunologic Evaluation of Personalized Peptide Vaccination for Patients with Advanced Malignant Glioma

    Naoki Yajima;Ryuya Yamanaka;Takashi Mine;Naoto Tsuchiya

  • Cellular and humoral immune responses to a human pancreatic cancer antigen, coactosin-like protein, originally defined by the SEREX method.

    Tetsuya Nakatsura;Tetsuya Nakatsura;Satoru Senju;Masaaki Ito;Yasuharu Nishimura

  • Suppressive effect of human natural killer cells on pokeweed mitogen-induced B cell differentiation.

    Unknown

  • Induction of cellular and humoral immune responses to tumor cells and peptides in HLA-A24 positive hormone-refractory prostate cancer patients by peptide vaccination.

    Masanori Noguchi;Kazuhiko Kobayashi;Norie Suetsugu;Katsurou Tomiyasu

  • Induction of Cellular Immune Responses to Tumor Cells and Peptides in Colorectal Cancer Patients by Vaccination with SART3 Peptides

    Yoshiaki Miyagi;Nobue Imai;Teruo Sasatomi;Akira Yamada

  • Identification of a SART-1-derived peptide capable of inducing HLA-A24-restricted and tumor-specific cytotoxic T lymphocytes.

    Megumi Kikuchi;Masanobu Nakao;Yoshiko Inoue;Kazuko Matsunaga

  • Humoral responses to peptides correlate with overall survival in advanced cancer patients vaccinated with peptides based on pre-existing, peptide-specific cellular responses.

    Takashi Mine;Yuji Sato;Masanori Noguchi;Teruo Sasatomi

Frequent Co-Authors

Akira Yamada
Akira Yamada Kurume University
Michio Sata
Michio Sata Kurume University
Satoru Todo
Satoru Todo Hokkaido University
Manabu Mochizuki
Manabu Mochizuki Tokyo Medical and Dental University
Seiji Naito
Seiji Naito Kyushu University
Bernard A. FoxEarle
Bernard A. FoxEarle Earle A. Chiles Research Institute
Akinori Kimura
Akinori Kimura Tokyo Medical and Dental University
Noriyuki Sato
Noriyuki Sato Sapporo Medical University
Toshihiko Torigoe
Toshihiko Torigoe Sapporo Medical University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students interested in Immunology, pursuing a related nursing degree can open diverse career opportunities in healthcare and research. Many professionals choose to advance their education through an accelerated nurse practitioner program, which provides a faster track to becoming a nurse practitioner with strong clinical skills applicable in immunology-focused medical settings.

Those transitioning from general nursing roles may explore acute care nurse practitioner certification to specialize in treating patients with complex immune-related conditions. This certification builds expertise for managing acute illnesses and contributes valuable knowledge to immunology-based healthcare teams.

For individuals without a nursing background, programs like the best online RN programs for non nurses provide flexible pathways into nursing careers. These programs help non-nurses gain essential clinical foundations that support further specialization in immunological research or patient care.

Additionally, many aspiring nurses begin with the easiest ABSN programs to get into, enabling quicker entry into the nursing field. From there, they can pursue advanced credentials to bridge nursing with immunology expertise, expanding career opportunities.

Best Scientists Citing Kyogo Itoh

Trending Scientists

Recently Published Articles